Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
Klaassen, D J
Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer. [electronic resource] - Cancer chemotherapy reports - 667-9 p. digital
Publication Type: Journal Article
0069-0112
Administration, Oral
Anemia--chemically induced
Antineoplastic Agents--administration & dosage
Cyclohexanes--administration & dosage
Drug Evaluation
Female
Gastrointestinal Neoplasms--drug therapy
Humans
Leukopenia--chemically induced
Male
Nitrosourea Compounds--administration & dosage
Thrombocytopenia--chemically induced
Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer. [electronic resource] - Cancer chemotherapy reports - 667-9 p. digital
Publication Type: Journal Article
0069-0112
Administration, Oral
Anemia--chemically induced
Antineoplastic Agents--administration & dosage
Cyclohexanes--administration & dosage
Drug Evaluation
Female
Gastrointestinal Neoplasms--drug therapy
Humans
Leukopenia--chemically induced
Male
Nitrosourea Compounds--administration & dosage
Thrombocytopenia--chemically induced